683 Capital Management, LLC Greenwich Life Sciences, Inc. Transaction History

683 Capital Management, LLC

  • $1.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$7.77 - $12.3 $152,323 - $241,129
19,604 New
19,604 $206,000
Q1 2023

May 15, 2023
SELL
$12.12 - $20.8 $11,550 - $19,822
-953 Reduced 8.15%
10,747 $148,000
Q4 2022

Feb 14, 2023
BUY
$9.04 - $16.88 $105,767 - $197,496
11,700 New
11,700 $177,000

Others Institutions Holding GLSI

# of Institutions
38
Shares Held
1.1M
Call Options Held
0
Put Options Held
0
View Full List

About Greenwich LifeSciences, Inc.

GLSI Quotes by TradingView
  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $158M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track 683 Capital Management, LLC Portfolio

Follow 683 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email